Open Access Open Access  Restricted Access Subscription or Fee Access

CBD—“Wonder Drug†Of The Future

Paul J. Flaer

Abstract


The traditional “wonder drug” in pharmacology is aspirin, well known for its properties of pain control, lowering elevated body temperature, fighting inflammation, and decreasing blood coagulation. Aspirin, as a non-steroidal anti-inflammatory drug (NSAID) is a preventative drug as well as a therapeutic one. The Framingham heart study has concluded that a low dose aspirin regimen (81 mg/day) will help prevent cardiovascular disease and stroke. On the other hand, CBD (cannabidiol) may be designated the “wonder drug” of the future! CBD, a major extract of most strains of cannabis has a broad-spectrum of pharmacological properties including anxiolytic, anticompulsive, antipsychotic, neuroprotective, analgesic, anti-emetic, antispasmodic, anti-inflammatory, anti-neoplastic, and the lowering of intraocular pressure. CBD has potential applications in medical therapy for diverse conditions including anxiety-related disorders, psychogenic disorders, glaucoma, epilepsy, migraine headaches, Crohn’s disease, cancer chemotherapy, and HIV/AIDS. CBD is non-toxic and safe to most body systems whereas even moderate doses of aspirin can be ulcerative to the stomach and toxic to the kidneys.

 

Keywords: Cannabidiol, CBD, cannabis, aspirin, anxiety disorders, OCD, aspirin

Cite this Article

 

Flaer Paul J. CBD: “Wonder Drug” of the Future. Research & Reviews: Journal of Neuroscience. 2017; 7(1): 1–5p.


Full Text:

PDF

Refbacks

  • There are currently no refbacks.